MoneyWorks4Me

Lasa Supergenerics informs about press release

14 Feb 2018 Evaluate

Lasa Supergenerics has informed about the Press release on the financial performance of the Company for the Q3 FY18.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..